Pharmacokinetic and Pharmacodynamic (PK/PD) studies for preclinical development
The PK/PD studies are an important step in the Drug Discovery process. PK/PD analysis generate high quality data on pharmacokinetic (PK) and pharmacodynamic (PD) of drug candidate.
CRO services help you in your drug discovery project providing PK services and PD services.
Oncodesign Services, a CRO specialized in Pharmacodynamic (PD) and Pharmacokinetic (PK) studies
The Oncodesign Services PK/PD department gather experts in Drug Discovery to support your research programs. Our laboratories are BSL1, BSL2 and BSL3 and AAALAC accredited for our animal care and use program.
Our PK/PD services include:
- In vivo Pharmacodynamic (PD) services
- In vivo Pharmacokinetic (PK) services
- PK/PD modelling
- DMPK analysis
- PK mouse models
- Genetically modified PK mouse models, including models designed for better evaluation of human antibody PK profiles (e.g. huFcRn/HAS mice)
- PK rat models
- Non-human primate (NHP) PK models
PK studies can be short-term (e.g. for small molecules over 24 hours) or long-term (e.g. for biologics over several weeks), combined with bioanalytical method ad hoc development and/or method transfer. We evaluate the relationship assessment studies in rodents (including pathological models) and other animal species (drug exposure and disease-related).
Based on our extensive experience, Oncodesign Services’ team offers support and all along your preclinical projects with fast cycles times and an access to latest innovative technologies.
